Global Cell-Based Assays Market size is expected to be worth around US$ 37.1 Billion by 2032 from US$ 17.7 Billion in 2023, growing at a CAGR of 8.8% ...
All-in-one kit enables in-house, in vitro profiling of human drug-induced liver injury Rapid access to CN Bio’s FDA-recognized human DILI assay to optimize and de-risk drug candidate selection ...
their toxicity varies from compound to compound." Human immune and liver cell lines were used in the study. Skin sensitization potential was assessed using the KeratinoSens assay, which has been ...